; The Yale Diabetes Research Center (DRC) was established in 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the University. The DRC brings together a multidisciplinary group of over 100 member and associate member scientists as well as professional supporting staff, new Investigators and research trainees from in 16 departments and 4 colleges or schools at Yale University The scope ofthe research activities ofthe membership is very broad, ranging from basic molecular biology to whole body physiology and the treatment of diabetic patients. The members, however, share a common interest in research that is related to diabetes and metabolism or is fundamental to understanding its pathogenesis or for the development of new treatment strategies. The design of the Yale DRC is aimed at developing an Infrastructure that could serve as a catalyst to stimulate innovative diabetes-related research. The cornerstone of the DRC is its five Research Cores that provide funded basic and clinical investigators with the opportunity to more efficiently utilize resources and expand the scope of their research programs. The Clinical Metabolism and the Diabetes Translational Cores facilitate metabolic research in patients, whereas the Molecular Genetic Mouse Core, Physiology and Cell Biology Cores that comprise the more basic science focus of the Center offer investigators the tools to create and test novel animal models starting from the molecule and ending with biological outcomes. The Administrative Core oversees the operation ofthe Center, Its Pilot/Feasibility Project and Enrichment Programs, and helps to coordinate patient-based research in diabetes. The goals ofthe DRC are to: 1) stimulate multldisciplinary Interactions, particularly between basic and clinical scientists;2) encourage established Investigators not presently working in diabetes-related areas, to bring their expertise to bear on problems relevant to diabetes;3) efficiently organize time consuming and/or costly techniques through Core facilities to enhance the productivity of investigators conducting research in diabetes related areas;4) promote new research programs through pilot feasibility projects;5) enhance the quality of research training, and 6) create a stimulating institutional environment that enhances research efforts by its members to develop new strategies to prevent and treat diabetes and related metabolic disorders at the local and national level.
; The Yale Diabetes Research Center provides the infrastructure to support a wide spectrum clinical and basic scientists who are working collaboratively to understand why diabetes develops, and to translate discoveries from the bench to the bedside and ultimately to new strategies for the prevention and treatment of patients with, or who are at risk for developing diabetes.
|Xu, Ke; Zhang, Xinyu; Wang, Zuoheng et al. (2018) Epigenome-wide association analysis revealed that SOCS3 methylation influences the effect of cumulative stress on obesity. Biol Psychol 131:63-71|
|Perry, Rachel J; Peng, Liang; Cline, Gary W et al. (2018) Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes. Cell Metab 27:210-217.e3|
|Xiang, Anny H; Trigo, Enrique; Martinez, Mayra et al. (2018) Impact of Gastric Banding Versus Metformin on ?-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes. Diabetes Care 41:2544-2551|
|Belfort-DeAguiar, Renata; Seo, Dongju; Lacadie, Cheryl et al. (2018) Humans with obesity have disordered brain responses to food images during physiological hyperglycemia. Am J Physiol Endocrinol Metab 314:E522-E529|
|Szczepanik, Marian; Majewska-Szczepanik, Monika; Wong, Florence S et al. (2018) Regulation of contact sensitivity in non-obese diabetic (NOD) mice by innate immunity. Contact Dermatitis 79:197-207|
|Yu, Hua; Paiva, Ricardo; Flavell, Richard A (2018) Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective. Immunology 153:161-170|
|Samuel, Varman T; Shulman, Gerald I (2018) Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. Cell Metab 27:22-41|
|Abulizi, Abudukadier; Camporez, João-Paulo; Zhang, Dongyan et al. (2018) Ectopic lipid deposition mediates insulin resistance in adipose specific 11?-Hydroxysteroid dehydrogenase type 1 transgenic mice. Metabolism :|
|Rash, Brian G; Micali, Nicola; Huttner, Anita J et al. (2018) Metabolic regulation and glucose sensitivity of cortical radial glial cells. Proc Natl Acad Sci U S A 115:10142-10147|
|Kumar, Nikit; Leonzino, Marianna; Hancock-Cerutti, William et al. (2018) VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. J Cell Biol 217:3625-3639|
Showing the most recent 10 out of 620 publications